Have a feature idea you'd love to see implemented?
Let us know!
TELA TELA Bio Inc
Price (delayed)
$2.89
Market cap
$113.83M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.69
Enterprise value
$137.24M
TELA Bio Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is
Highlights
TELA's revenue is up by 29% year-on-year and by 6% since the previous quarter
TELA Bio's gross profit has increased by 28% YoY and by 6% from the previous quarter
The equity has dropped by 121% year-on-year
The quick ratio has dropped by 60% year-on-year and by 28% since the previous quarter
Key stats
What are the main financial stats of TELA
Market
Valuations
Earnings
Shares outstanding
39.39M
Market cap
$113.83M
Enterprise value
$137.24M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2
Revenue
$68.65M
EBIT
-$36.17M
EBITDA
-$35.26M
Free cash flow
-$46.03M
Per share
Balance sheet
Liquidity
EPS
-$1.69
Free cash flow per share
-$1.86
Book value per share
-$0.25
Revenue per share
$2.78
TBVPS
$2.07
Total assets
$53.02M
Total liabilities
$59.29M
Debt
$40.97M
Equity
-$6.27M
Working capital
$27.27M
Debt to equity
-6.53
Current ratio
2.62
Quick ratio
1.71
Net debt/EBITDA
-0.66
Margins
Efficiency
Dividend
EBITDA margin
-51.4%
Gross margin
68.3%
Net margin
-60.5%
Operating margin
-66.5%
Return on assets
-63.1%
Return on equity
-556.2%
Return on invested capital
-64.2%
Return on capital employed
-100%
Return on sales
-52.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TELA stock price
How has the TELA Bio stock price performed over time
Intraday
-0.34%
1 week
-4.93%
1 month
15.14%
1 year
-40.53%
YTD
-56.34%
QTD
14.23%
Financial performance
How have TELA Bio's revenue and profit performed over time
Revenue
$68.65M
Gross profit
$46.89M
Operating income
-$45.62M
Net income
-$41.52M
Gross margin
68.3%
Net margin
-60.5%
TELA's revenue is up by 29% year-on-year and by 6% since the previous quarter
TELA Bio's gross profit has increased by 28% YoY and by 6% from the previous quarter
TELA Bio's net margin has increased by 27% YoY and by 7% from the previous quarter
The operating margin has grown by 14% YoY and by 7% from the previous quarter
Growth
What is TELA Bio's growth rate over time
Valuation
What is TELA Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
1.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2
TELA Bio's EPS has increased by 16% YoY
The equity has dropped by 121% year-on-year
TELA's price to sales (P/S) is 81% less than its 5-year quarterly average of 5.6 and 45% less than its last 4 quarters average of 1.9
TELA's revenue is up by 29% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is TELA Bio business performance
TELA Bio's return on equity has shrunk by 180% YoY and by 120% QoQ
TELA Bio's ROS has increased by 28% YoY and by 7% from the previous quarter
TELA's ROIC is up by 13% YoY and by 4.2% QoQ
TELA's ROA is down by 11% since the previous quarter and by 11% year-on-year
Dividends
What is TELA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TELA.
Financial health
How did TELA Bio financials performed over time
TELA's total assets is 11% less than its total liabilities
The quick ratio has dropped by 60% year-on-year and by 28% since the previous quarter
The current ratio has plunged by 51% YoY and by 23% from the previous quarter
TELA Bio's debt to equity has shrunk by 146% QoQ
The equity has dropped by 121% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.